7.2 Cystic Fibrosis Pathogens and Quantitative Reporting

7.2 Cystic Fibrosis Pathogens and Quantitative Reporting

Quick Answer: Protected-brush cultures are often interpreted around 10^3 CFU/mL, BAL around 10^4 CFU/mL, and endotracheal aspirates around 10^5 CFU/mL—typical ranges used in clinical microbiology, with each laboratory following its validated procedure. Cystic fibrosis plates must recover S. aureus (mannitol salt), Pseudomonas spp., H. influenzae (chocolate, not hidden under mucoid growth), and B. cepacia complex (OFPBL, BCSA, or PC agar). Mucoid P. aeruginosa alginate and B. cepacia isolation are infection-control and prognostic facts.

Outline II.D.2 asks for the significance of quantitative and semiquantitative reporting. Outline II.D.4.c names the cystic fibrosis pathogen set. Together they test whether you can turn a number on a report into a clinical meaning and whether you can find a slow, selective, or hidden organism in a specimen that looks like glue.

Why counts matter

The lower airway is not sterile once a tube or chronic disease is present. A single colony of P. aeruginosa from a protected brush does not mean the same thing as a lawn from an endotracheal aspirate. Quantitative culture estimates CFU per milliliter of specimen. Semiquantitative culture uses 1+ to 4+ or rare/few/moderate/many after a standardized streak. Both exist to answer one question: is this organism present at a burden that correlates with pneumonia, or is it colonizing the tube and mouth?

Typical interpretive ranges used in clinical microbiology practice (and the numbers you should recognize on M) are:

These are typical ranges, not a single CLIA-mandated universal cutoff. Laboratories validate dilution schemes, loop volumes, and reporting comments. If the stem says “the laboratory’s validated BAL threshold is 10^4 CFU/mL,” honor that SOP. If the stem gives no SOP, the 10^3 / 10^4 / 10^5 ladder is the pattern to apply.

Correlate the count with the Gram stain. Intracellular organisms in neutrophils on a cytocentrifuged BAL smear support infection even before colonies mature. A 10^5 Candida count from ETA in a patient without yeast on stain is more often colonization. Quantitation without morphology is incomplete.

Semiquantitative reporting still has meaning. Heavy, predominant growth of one morphotype from a quality sputum is more significant than mixed 1+ oral flora. “Rare S. aureus” from a dirty sputum is not the same report as “4+ mucoid P. aeruginosa” from a CF patient who is declining.

Cystic fibrosis pathogens on the M outline

CF sputum is thick, chronically infected, and microbiologically crowded. The outline’s major pathogens are:

Other organisms (Achromobacter, nontuberculous mycobacteria, Aspergillus) appear in real CF care. They are not the M outline’s named set. Study the four that are listed, then use selective media so those four cannot be missed.

Selective media and a CF workup that actually finds the organism

A CF culture is not a community sputum planted on blood, chocolate, and MacConkey for 24 hours. Homogenization (often DTT or another liquefying agent), a battery of selective plates, and prolonged incubation (commonly 3–5 days, with some plates held longer per SOP) are the difference between “no Burkholderia” and a missed complex member.

Mannitol salt agar (7.5% NaCl, mannitol, phenol red) selects staphylococci. S. aureus usually ferments mannitol (yellow). MRSA still needs a cefoxitin screen, chromogenic MRSA agar, or mecA testing; MSA alone does not equal methicillin resistance. The plate’s job is to pull staphylococci out of a Pseudomonas lawn.

B. cepacia selective media are named on purpose:

• OFPBL — oxidation-fermentation polymyxin-bacitracin-lactose agar. Many B. cepacia complex isolates oxidize lactose and appear yellow.
• BCSA — Burkholderia cepacia selective agar, more inhibitory and often more sensitive than older PC formulations.
• PC agar — Pseudomonas cepacia agar, the historic name; still used in some procedures.

Growth on these media is presumptive, not a final identification. Confirm with biochemical panels, MALDI-TOF (with a database that distinguishes complex members when possible), or molecular methods. Misidentifying B. cepacia complex as Pseudomonas or Burkholderia gladioli has infection-control consequences.

Chocolate agar remains mandatory because H. influenzae will not compete on MacConkey and may not grow on sheep blood without V factor. A bacitracin disk on chocolate suppresses some Gram-positive flora and creates a window where Haemophilus can satellite. If the plate is a mucoid Pseudomonas smear, look at the edge and underneath. Lift or subculture the mucoid film. A workup that reports only the swarm is an incomplete CF culture.

Mucoid Pseudomonas and alginate

In CF airways, P. aeruginosa often switches to a mucoid phenotype. The slime is alginate, an exopolysaccharide overproduced after regulatory mutations (classically mucA). Alginate is not the same as the pneumococcal capsule, but it plays a similar antiphagocytic, biofilm-building role. Mucoid colonies look wet and runny, can drip onto neighboring streaks, and may be harder to pick for identification or susceptibility testing. Convert a mucoid isolate to a workable inoculum per SOP; do not skip AST because the colony is ugly.

Mucoid conversion correlates with chronic infection and poorer lung function. Nonmucoid P. aeruginosa can still be present on the same plate. Report both phenotypes when the procedure calls for it. Oxidase, pigment, grape odor, and growth at 42 °C still support P. aeruginosa, but pigment may be muted in mucoid strains.

Burkholderia cepacia complex and infection control

B. cepacia complex is a group of related species (historically genomovars; B. cenocepacia and B. multivorans are frequent in CF). Two exam-level facts dominate:

1. Infection control. The complex spreads in CF clinics and social settings. Patients who harbor it are typically isolated from other CF patients—separate clinic days, rooms, and spirometers per institutional policy. A missed identification is an outbreak waiting to happen.
2. Cepacia syndrome. A subset of patients progress to rapidly fatal necrotizing pneumonia and bacteremia. That risk, plus intrinsic resistance to many antipseudomonal agents, is why the selective-agar hunt is not optional.

The complex is often oxidase variable, can grow on MacConkey, and may oxidize lactose or maltose. It is not S. maltophilia and not P. aeruginosa. If MALDI or biochemicals are equivocal, do not issue a casual “Pseudomonas species” report on a CF patient without completing the Burkholderia workup.

Slow growers and small-colony variants

S. aureus small-colony variants (SCVs) are tiny, often nonhemolytic or weakly hemolytic colonies that can look like coagulase-negative staphylococci or even coryneforms. Many are auxotrophic for hemin, menadione, or thymidine and persist intracellularly. They are associated with chronic CF infection and with patients who have received long-term antibiotics (including trimethoprim-sulfamethoxazole or aminoglycosides). Hold plates, use MSA, and pick pinpoint catalase-positive cocci. A 24-hour blood-agar glance will miss them.

B. cepacia complex and some Haemophilus isolates can also be slow. A CF culture signed out at 24 hours with “normal flora and Pseudomonas” is not finished.

Do not let swarming Proteus or mucoid Pseudomonas hide Haemophilus

This is a technique item, not trivia. Proteus swarming can veil an entire blood agar plate. Mucoid P. aeruginosa can bury pinpoint Haemophilus on chocolate. The M-level workup:

• Include chocolate agar on every CF and lower-tract pathogen hunt that must recover H. influenzae.
• Place a bacitracin disk on chocolate to suppress competing Gram-positive flora and create a readable zone.
• Use CNA or PEA if needed to recover Gram-positive pathogens from a swarm, and MacConkey or CLED-type inhibition to see Gram-negatives without swarming.
• Subculture under and around mucoid colonies rather than assuming the mucoid organism is the only isolate.
• Incubate chocolate in CO2 and hold it; Haemophilus is not a 12-hour organism in a Pseudomonas swamp.

Quantitative reporting and CF workup share a theme: the organism that kills the patient may not be the prettiest colony. Counts tell you whether a BAL isolate is likely pneumonia. Selective media and a skeptical eye tell you whether H. influenzae, an SCV, or B. cepacia complex is hiding under alginate. Laboratories follow validated procedures for both the math and the media—but the outline expects you to know why those procedures exist.